| Primary information |
|---|
| ID | 13482 |
| Uniprot ID | P83059 |
| Description | Kininogen-2 (BOK-2) [Cleaved into- [Thr6]-bradykinin; Bradykinin inhibitor peptide DV-28 (DV-28 amide)] |
| Organism | Bombina orientalis |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amphibia; Batrachia; Anura; Bombinatoridae; Bombina (firebellied toads); Bombina orientalis (Oriental fire-bellied toad) |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the bradykinin-related peptide family. |
| Tissue Specificity | Expressed by the skin glands. |
| Post Translational Modification | NA |
| Function | [[Thr6]-bradykinin]- inhibits ACE with a Ki of 1.6 uM; and targets B2 bradykinin receptor (BDKRB2). Provokes contraction of smooth muscle preparation (ileum). In vivo; induces an early hyperalgesic effects in living rats after intraplantar injection. |
| Length | 161 |
| Molecular Weight | 19 |
| Name | Kininogen-2 |
| Sequence | ERNNRDYPIRTHLHGPHIPRNNRDYPIRTHLHGHHIPRNVPESEEKTEQFLRDLSEISRLQRRPPGFTPFRGKFHSQSLRDLSEISRLQRRPPGFTPFRGKFHSQSLRDMYEIKGFKSAHGRPRVCPPGEQCPIWVG |
| Sequence map | 26-41 |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|